Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application Posted on November 7, 2013February 11, 2025 by Hannah Faulkner Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application
Using ClinicalTrials.gov to Understand the State of Clinical Research in Pulmonary, Critical Care, and Sleep Medicine Posted on October 16, 2013February 17, 2025 by Hannah Faulkner Using ClinicalTrials.gov to Understand the State of Clinical Research in Pulmonary, Critical Care, and Sleep Medicine
The State of Infectious Diseases Clinical Trials: A Systematic Review of ClinicalTrials.gov Posted on October 16, 2013February 17, 2025 by Hannah Faulkner The State of Infectious Diseases Clinical Trials: A Systematic Review of ClinicalTrials.gov
An Analysis of Registered Clinical Trials in Otolaryngology from 2007 to 2010 Posted on October 9, 2013February 17, 2025 by Hannah Faulkner An Analysis of Registered Clinical Trials in Otolaryngology from 2007 to 2010
Portfolio of Clinical Research in Adult Cardiovascular Disease as Reflected in ClinicalTrials.gov Posted on September 26, 2013February 17, 2025 by Hannah Faulkner Portfolio of Clinical Research in Adult Cardiovascular Disease as Reflected in ClinicalTrials.gov
Use of central institutional review boards for multicenter clinical trials in the United States: A review of the literature Posted on May 10, 2013February 11, 2025 by Hannah Faulkner Use of central institutional review boards for multicenter clinical trials in the United States: A review of the literature
Clinical Trials: Do Participants Feel Safe? Posted on May 10, 2013February 7, 2025 by Hannah Faulkner Clinical Trials: Do Participants Feel Safe?
New Executive Committee Members Named to CTTI Posted on May 7, 2013July 21, 2021 by Hannah Faulkner New Executive Committee Members Named to CTTI
Participants’ Perspectives on Safety Monitoring in Clinical Trials Posted on May 3, 2013February 11, 2025 by Hannah Faulkner Participants’ Perspectives on Safety Monitoring in Clinical Trials
Cancer Studies Often Lack Necessary Rigor to Answer Key Questions Posted on April 30, 2013February 17, 2025 by Hannah Faulkner Cancer Studies Often Lack Necessary Rigor to Answer Key Questions
